Stock Market Reviews

Read and share opinions on PRFX (PainReform Ltd.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• PainReform’s DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis
  Nov 12, 2025
• PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
  Nov 5, 2025
• PainReform Provides Business Update for the Six Months Ended June 30, 2025
  Oct 1, 2025
• PainReform/DeepSolar Accepted into NVIDIA Connect Program
  Aug 19, 2025
• PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System
  Aug 13, 2025
• PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio
  Jul 10, 2025
• Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
  May 27, 2025
• PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects
  May 7, 2025
• PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization Market
  Apr 10, 2025
• PainReform Provides Year-End Business Update
  Apr 7, 2025
• PainReform completes acquisition of DeepSolar
  Mar 6, 2025
• PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
  Mar 5, 2025
• PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity
  Feb 18, 2025
• PainReform Faces Setback in Phase 3 Trial for PRF-110
  Dec 28, 2024
• PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110
  Dec 27, 2024
• PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
  Nov 20, 2024